Check out our most popular compounded medications! Get Started
Morphine Sulfate 30 mg Slow Release Suppository is a solid dosage form designed for insertion into a body cavity, typically the rectum or vagina. It gradually dissolves or melts to release Morphine Sulfate, a potent painkiller, for local or systemic absorption. This formulation is primarily used to manage chronic, cancer, postoperative, neuropathic, and end-of-life pain.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 30 mg Slow Release Suppository is a prescription medication specifically designed to provide relief from moderate to severe pain. This long-acting opioid medication is administered rectally, dissolving or melting to release the medication for local or systemic absorption. It is particularly beneficial for patients who are unable to take oral medications or require consistent pain relief over an extended period.
This formulation is indicated for the relief of moderate to severe pain in patients who require continuous, around-the-clock opioid analgesia. It is commonly used to manage chronic pain conditions such as cancer, arthritis, and neuropathic pain. The slow-release feature of this suppository ensures a sustained release of medication, providing long-lasting pain relief.
It is crucial to adhere to the instructions provided by your healthcare provider and take the medication exactly as prescribed. Monitoring for signs of opioid misuse or abuse, such as taking more than the prescribed dose or taking the medication more frequently than prescribed, is also important.
If you have any questions or concerns about Morphine Sulfate 30 mg Slow Release Suppository or any other medication, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of experienced compounding pharmacists is here to assist you with your medication needs and provide you with the necessary information to ensure safe and appropriate use of your medications.
Morphine Sulfate 30 mg Slow Release Suppository is a potent analgesic formulation designed to provide relief from moderate to severe pain. This solid dosage form is inserted into a body cavity, typically the rectum or vagina, where it dissolves or melts to release the medication.
However, it is crucial to note that this formulation is contraindicated in patients with severe renal impairment or those with a known hypersensitivity to morphine or other opioid analgesics. It is also not recommended for use in patients with a history of substance abuse or addiction due to the risk of dependency and misuse.
Patients under this medication should be closely monitored for signs of respiratory depression, sedation, and constipation, which are common side effects of opioid analgesics. Concurrent use of alcohol and other CNS depressants should be avoided as it may exacerbate these side effects.
It is essential for patients to understand the risks associated with the use of this medication, including the potential for addiction, abuse, and misuse. They should be advised to strictly adhere to the prescribed dosage and not to exceed the recommended dose. It is also important for patients to understand that the medication should be used only as directed by their healthcare provider.
If any questions or concerns arise regarding the use of Morphine Sulfate 30 mg Slow Release Suppository, patients are encouraged to consult with their healthcare provider or pharmacist for further information and guidance.
Morphine Sulfate 30 mg Slow Release Suppository is a potent analgesic medication designed to alleviate moderate to severe pain. The active ingredient, morphine, is released gradually over an extended period, providing consistent and long-lasting pain relief. This slow-release mechanism also helps to minimize the occurrence of potential side effects, such as nausea, vomiting, and constipation, which are often associated with morphine use.
The suppository is typically inserted into the rectum, where it dissolves or melts, allowing the medication to be absorbed directly into the bloodstream. This method of administration ensures a more efficient absorption of the medication. It is crucial to use the suppository as directed by your healthcare provider and to follow the provided instructions meticulously. This will ensure optimal absorption of the medication and minimize the risk of potential side effects.
If you have any queries or concerns regarding the use of Morphine Sulfate 30 mg Slow Release Suppository, or if you experience any adverse reactions, it is recommended to consult with your healthcare provider immediately. They can provide you with the necessary guidance and support to ensure safe and appropriate use of this medication.
A Morphine Sulfate 30 mg Slow Release Suppository is a solid dosage form of medication that is inserted into a body cavity, typically the rectum or vagina. It is designed to dissolve or melt slowly to release the medication for local or systemic absorption.
Once inserted into the body, the suppository dissolves or melts at body temperature. The Morphine Sulfate is then slowly released into the body over a period of time, allowing for a controlled and sustained delivery of the medication.
The slow release feature allows for a steady and controlled release of Morphine Sulfate into the body. This ensures that the medication is delivered over a longer period of time, reducing the need for frequent dosing and providing consistent pain relief.
These suppositories should be stored in a cool, dry place, away from direct sunlight and heat. They should also be kept out of reach of children and pets to prevent accidental ingestion.
The frequency of use will depend on your doctor's prescription.
If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Common side effects may include constipation, nausea, and dizziness. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Before using this medication, tell your doctor or pharmacist if you are pregnant or breastfeeding. This medication may have undesirable effects on a nursing infant or a fetus.
This medication may cause drowsiness or dizziness. Do not drive, use machinery, or do anything that needs alertness until you can do it safely.
Alcohol can increase the risk of serious side effects, such as severe drowsiness or dizziness, and can even be fatal when combined with this medication. It is recommended to avoid alcohol while using this medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository
